According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

Specifically, the study — as published in “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association” — has linked ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among ...

The results were pretty astounding: Patients who used Ozempic had a whopping 70% lower risk of Alzheimer's than patients who ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy ...

Share on Pinterest Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing ... Alzheimer’s is a common type of dementia, accounting for around ...

Type 2 diabetes is a risk factor for dementia and Alzheimer’s. Novo Nordisk, which makes Ozempic and Wegovy ... semaglutide had a significantly lower risk for Alzheimer’s disease than those ...